Test Code IGA SUB GR IgA Subclasses, Serum
Reporting Name
IgA Subclasses, SUseful For
Investigation of immune deficiency due to IgA2 deficiency
Evaluating patients with anaphylactic transfusion reactions
Specimen Required
Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Specimen Volume: 1 mL
Specimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Ambient | 7 days | ||
Frozen | 7 days |
Day(s) Performed
Monday, Wednesday, Friday
TAT: 3 - 4 days
Performing Laboratory

Method Name
Nephelometry
Method Description
In this Siemens Nephelometer II method, the light scattered onto the antigen-antibody complexes is measured. The intensity of the measured scattered light is proportional to the amount of antigen-antibody complexes in the sample under certain conditions. If the antibody volume is kept constant, the signal behaves proportionally to the antigen volume.
A reference curve is generated by a standard with a known antigen content on which the scattered light signals of the samples can be evaluated and calculated as an antigen concentration. Antigen-antibody complexes are formed when a sample containing antigen and the corresponding antiserum are put into a cuvette. A light beam is generated with an LED, which is transmitted through the cuvette. The light is scattered onto the immuno-complexes that are present. Antigen and antibody are mixed in the initial measurement, but no complex is formed yet. An antigen-antibody complex is formed in the final measurement.
The result is calculated by subtracting value of the final measurement from the initial measurement. The distribution of intensity of the scattered light depends on the ratio of the particle size of the antigen-antibody complexes to the radiated wavelength.(Unpublished Mayo method; Instruction manual: Siemens Nephelometer II, Version 3, Siemens, Inc., Newark, DE, 2008)
Reference Values
IgA
0-<5 months: 7-37 mg/dL
5-<9 months: 16-50 mg/dL
9-<15 months: 27-66 mg/dL
15-<24 months: 36-79 mg/dL
2-<4 years: 27-246 mg/dL
4-<7 years: 29-256 mg/dL
7-<10 years: 34-274 mg/dL
10-<13 years: 42-295 mg/dL
13-<16 years: 52-319 mg/dL
16-<18 years: 60-337 mg/dL
≥18 years: 61-356 mg/dL
IgA1
0-<5 months: 10-34 mg/dL
5-<9 months: 14-41 mg/dL
9-<15 months: 20-50 mg/dL
15-<24 months: 24-58 mg/dL
2-<4 years: 16-162 mg/dL
4-<7 years: 17-187 mg/dL
7-<10 years: 21-221 mg/dL
10-<13 years: 27-250 mg/dL
13-<16 years: 36-275 mg/dL
16-<18 years: 44-289 mg/dL
≥18 years: 50-314 mg/dL
IgA2
0-<5 months: 0.4-5.5 mg/dL
5-<9 months: 1.5-6.2 mg/dL
9-<15 months: 2.8-7.0 mg/dL
15-<24 months: 3.9-7.7 mg/dL
2-<4 years: 1.3-31.1 mg/dL
4-<7 years: 1.1-39.1 mg/dL
7-<10 years: 1.4-48.0 mg/dL
10-<13 years: 2.6-53.4 mg/dL
13-<16 years: 4.7-55.1 mg/dL
16-<18 years: 6.6-54.3 mg/dL
≥18 years: 9.7-156.0 mg/dL
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82784
82787 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
IGAS | IgA Subclasses, S | 87552-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
IGA_ | IgA | 2458-8 |
IGA1_ | IgA1 | 6886-6 |
IGA2_ | IgA2 | 6939-3 |
Report Available
2 to 4 daysReject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |